Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
ClinicalTrials.gov study NCT06366802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04017130. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06425991. IPD Sharing: YES. Countries: 11. Publications: 0.
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem
ClinicalTrials.gov study NCT05947136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy with Either Intravenous or Subcutaneous Isatuximab in Patients with Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05804032. IPD Sharing: NO. Countries: 2. Publications: 0.
Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma
ClinicalTrials.gov study NCT00335647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT06232707. IPD Sharing: YES. Countries: 27. Publications: 0.
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04268498. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
ClinicalTrials.gov study NCT06615479. IPD Sharing: YES. Countries: 31. Publications: 0.
A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)
ClinicalTrials.gov study NCT02092922. IPD Sharing: YES. Countries: 8. Publications: 0.
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00004072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00482495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00006232. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
ClinicalTrials.gov study NCT06209606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT01183949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)
ClinicalTrials.gov study NCT00473590. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
ClinicalTrials.gov study NCT00288028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00005987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
ClinicalTrials.gov study NCT05889221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05312255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.